ABOUT CENCORA
Cencora combines core pharmaceutical distribution with innovative business solutions to help our partners across the healthcare spectrum get medications to the patients who need them. Biopharmaceutical companies benefit from the global scale and resources of a company ranked #10 on the Fortune 500, combined with local expertise provided by more than 51,000 team members worldwide. Learn more at www.cencora.com.
We help build foundations for successful product submissions, launches, and commercialization across the globe. Our strategic, integrated solutions – encompassing regulatory, safety, market access and more – help accelerate time-to-market while optimizing patient access and revenue from marketed products.
VIDEOS AND WEBINARS
-
![Cencora - ISPOR]( "Harmonizing Health Technology Assessment: PICO Consolidation Under The EU HTA Regulation")
Harmonizing Health Technology Assessment: PICO Consolidation Under The EU HTA RegulationDiscover how the EU HTA Regulation is redefining market access through PICO consolidation and learn strategic approaches to evidence generation, comparator selection, and the integration of real-world data.
-
![Cencora - Nexus 25]( "Insights For Innovation: AMCP Nexus 2025 Educational Videos")
Insights For Innovation: AMCP Nexus 2025 Educational VideosExplore our curated collection of expert-led educational sessions from AMCP Nexus 2025, covering key topics including updates on AMCP Format 5.0, strategic payer engagement tactics, AI-driven innovations, and more.
-
![Cencora - oncology webinar]( "Navigating The Regulatory Complexities Of Targeted Medicines In Oncology")
Navigating The Regulatory Complexities Of Targeted Medicines In OncologyExplore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines. Learn about the challenges in translational medicine and key clinical development considerations.
-
![Cencora - Summer Shorts - stats]( "Transforming Drug Development With Statistical Science")
Transforming Drug Development With Statistical ScienceExplore how statistical science and computational biology can accelerate drug development. Learn how innovative trial designs and Bayesian statistics can lead to more efficient and successful clinical trials.
-
![Cencora - Summer Shorts - Thinking Ahead]( "Thinking Ahead: How Integrated Development Plans Improve Product Success")
Thinking Ahead: How Integrated Development Plans Improve Product SuccessHow can integrated development planning reduce development timelines and increase your chances of commercialization success? Industry experts reveal how this approach helps avoid common pitfalls.
-
![Cencora - Shaila Yoshida]( "Understanding The Evolving Landscape Of Anti-Obesity Medication (AOMs)")
Understanding The Evolving Landscape Of Anti-Obesity Medication (AOMs)Discover the evolving landscape of AOMs as a value and access expert shares the latest payer coverage trends, concerns, and strategies. Learn how payers are making critical coverage decisions.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
ARTICLES
-
![GettyImages-1318426446 profile]( "Strategic Management Of The Mature Product Portfolio")
Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.
-
![GettyImages-2235582013-prefilled-syringe-liquid-manufacturing]( "The Need For Adaptive Distribution Partners For Cell And Gene Therapies")
Optimize your commercial strategy by exploring how adaptive distribution models navigate reimbursement challenges and improve patient access. Partner early to align workflows and ensure operational success.
-
![iStock-1287080337-lab-microscope-scientist-research.jpg]( "Unraveling The Complexity Of Cell Therapy: Advancements And Challenges")
Cell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.
-
![GettyImages-1451133080 meeting, strategy]( "Navigating The Complex Regulatory World Of ATMPs/CGTs")
Discover how shifting definitions for ATMPs and CGTs impact global development strategies, from CMC validation requirements to navigating the latest European pharmaceutical legislation and expedited regulatory pathways.
-
![Cencora - 26 trends]( "Unlock The Future Of Market Access In 2026: A Guide To Navigating A Shifting Healthcare Landscape")
Navigating the future healthcare landscape requires early strategic planning and organizational agility to manage policy shifts. From AI implementation to global pricing dynamics, understanding these trends is essential for ensuring timely patient access.
WHITE PAPERS
-
![GettyImages-692413188 lab research]( "Project Orbis Drug Registration 2025")
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
![GettyImages-158649166 assay]( "Unlock Oncology Success With A Comprehensive Commercialization Guide")
Navigate the complex process of bringing an oncology therapy to market, from regulatory planning to patient access and supply chain logistics, with this comprehensive handbook for developers.
-
![GettyImages-891264822 planning, meeting]( "Why An Integrated Approach Ensures Smooth Entry Into The European Market")
Simplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.
PODCASTS
-
![Digital-marketing-GettyImages-1051659276]( "Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy")
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty PharmacyTune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
![Cencora PharmaLex - PlX talks 30]( "An Overview Of Contamination Control Strategy (CCS)")
An Overview Of Contamination Control Strategy (CCS)Join experts Londa Ritchey and Patrick Nieuwenhuizen as they explore the key role of a contamination control strategy in Annex 1 for ensuring patient safety and continuous manufacturing improvement.
-
![Cencora - PharmaLex Talks 28]( "Early Access Programs: What They Are And How To Plan For Them")
Early Access Programs: What They Are And How To Plan For ThemExplore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
-
![Cencora - PharmaLex Talks 27]( "Assessing Gaps And Achieving Compliance With Annex 1")
Assessing Gaps And Achieving Compliance With Annex 1In this podcast episode on Annex 1 compliance and gap assessment, Patrick Nieuwenhuizen shares his insights and expertise gleaned from extensive experience in pharmaceutical regulation and compliance.
-
![Cencora - PharmaLex Talks 26]( "Navigating The Process Of Technology Transfer")
Navigating The Process Of Technology TransferOlena Chervonenko, Associate Director Quality Management and Compliance at PharmaLex, provides deeper insights into technology transfer and essential factors for achieving success.
E-BOOKS AND OTHER INSIGHTS
-
![GettyImages-2235582013-prefilled-syringe-liquid-manufacturing]( "The Need For Adaptive Distribution Partners For Cell And Gene Therapies")
The Need For Adaptive Distribution Partners For Cell And Gene TherapiesOptimize your commercial strategy by exploring how adaptive distribution models navigate reimbursement challenges and improve patient access. Partner early to align workflows and ensure operational success.
-
![GettyImages-521848481 clinical trial, patient, diversity]( "Partnering With Health Systems: Essential Tips For CGT Commercialization")
Partnering With Health Systems: Essential Tips For CGT CommercializationSuccessful cell and gene therapy commercialization requires early, detailed manufacturer collaboration with health systems to ensure scalable operations and seamless patient access beyond the clinical trial.
-
![GettyImages-657049072 vaccine, pharma]( "Navigating The CGT Supply Chain: Key Logistical Challenges And Solutions")
Navigating The CGT Supply Chain: Key Logistical Challenges And SolutionsCommercializing cell and gene therapies requires overcoming complex logistical hurdles. Customized strategies for temperature control, compliance, and end-to-end delivery are crucial to prevent supply chain issues.
